Long-term augmentation therapy with Alpha-1 Antitrypsin in an MZ-AAT severe persistent asthma

Long-term augmentation therapy with Alpha-1 Antitrypsin in an MZ-AAT severe persistent asthma

A young Caucasian female with severe bronchial asthma and Alpha1-antitrypsin (AAT) deficiency, MZ phenotype, experienced a quick and severe limitation of her physical capacity, which negatively affected her psychological state and social life, though she was under a strong antiasthmatic treatment. G...

Full description

Bibliographic Details
Main Authors:	I. Blanco, H. Canto, J. Flóres, C. Camblor, V. Cárcaba, F.J. de Serres, S. Janciauskiene, E.F. Bustillo
Format:	Article
Language:	English
Published:	PAGEPress Publications 2016-01-01
Series:	Monaldi Archives for Chest Disease
Subjects:	Bronchial asthma Augmentation therapy with Alpha-1 antitrypsin SerpinA1 Alpha-1 Antitrypsin phenotypes Alpha-1 Antitrypsin deficiency augmentation therapy
Online Access:	https://www.monaldi-archives.org/index.php/macd/article/view/380

Similar Items

Alpha-1 antitrypsin deficiency: outstanding questions and future directions
by: María Torres-Durán, et al.
Published: (2018-07-01)

The Course of AαVal541 as a Proteinase 3 Specific Neo-Epitope after Alpha-1-Antitrypsin Augmentation in Severe Deficient Patients
by: Iris G. M. Schouten, et al.
Published: (2021-07-01)

The impact of alpha-1 antitrypsin augmentation therapy on neutrophil-driven respiratory disease in deficient individuals
by: Dunlea DM, et al.
Published: (2018-03-01)

PROINFLAMMATORY CYTOKINE PROFILE IN PATIENTS WITH DIFFERENT ALPHA-1-ANTITRYPSIN PHENOTYPES
by: M. Yu. Pervakova, et al.
Published: (2016-12-01)

Clinical presentations of four patients with rare Alpha 1 Antitrypsin variants identified in a single US center
by: Friedrich Kueppers
Published: (2021-01-01)

Monocytes and Macrophages in Alpha-1 Antitrypsin Deficiency
by: Belchamber KBR, et al.
Published: (2020-12-01)

The Distribution of Alpha-1 Antitrypsin Genotypes Between Patients with COPD/Emphysema, Asthma and Bronchiectasis
by: Veith M, et al.
Published: (2020-11-01)

Implications of a Change of Paradigm in Alpha1 Antitrypsin Deficiency Augmentation Therapy: From Biochemical to Clinical Efficacy
by: José Luis López-Campos, et al.
Published: (2020-08-01)

Description of 22 new alpha-1 antitrypsin genetic variants
by: Céline Renoux, et al.
Published: (2018-09-01)

PI S and PI Z Alpha-1 antitrypsin deficiency worldwide. A review of existing genetic epidemiological data
by: F.J. de Serres, et al.
Published: (2016-02-01)

Estimates of PI*S and PI*Z Alpha-1 antitrypsin deficiency alleles prevalence in the Caribbean and North, Central and South America
by: F.J. de Serres, et al.
Published: (2016-01-01)

Alpha-1 Antitrypsin Augmentation Therapy Improves Survival in Severely Deficient Patients with Predicted FEV1 Between 10% and 60%: A Retrospective Analysis of the NHLBI Alpha-1 Antitrypsin Deficiency Registry
by: Rahaghi FF, et al.
Published: (2020-12-01)

Does urinary peptide content differ between COPD patients with and without inherited alpha-1 antitrypsin deficiency?
by: Carleo A, et al.
Published: (2017-03-01)

Methods of Purification and Application Procedures of Alpha1 Antitrypsin: A Long-Lasting History
by: Simona Viglio, et al.
Published: (2020-09-01)

Alpha-1 antitrypsin gene polymorphism in Chronic Obstructive Pulmonary Disease (COPD)
by: Sabri Denden, et al.
Published: (2010-01-01)

Alpha 1 antitrypsin distribution in an allergic asthmatic population sensitized to house dust mites
by: I. Suárez-Lorenzo, et al.
Published: (2018-11-01)

Evaluation of Alpha-1 Antitrypsin Levels and SERPINA1 Gene Polymorphisms in Sickle Cell Disease
by: Magda Oliveira Seixas Carvalho, et al.
Published: (2017-11-01)

Prevalence of the serpin peptidase inhibitor (alpha-1-antitrypsin) PI*S and PI*Z alleles in Brazilian children with liver disease
by: Guilherme Baldo, et al.
Published: (2008-01-01)

Protein modeling to assess the pathogenicity of rare variants of SERPINA1 in patients suspected of having Alpha 1 Antitrypsin Deficiency
by: Friedrich Kueppers, et al.
Published: (2019-07-01)

Clinical utility of alpha-1 proteinase inhibitor in the management of adult patients with severe alpha-1 antitrypsin deficiency: a review of the current literature
by: Parr DG, et al.
Published: (2017-07-01)

Polymorphism of alpha-1-antitrypsin in hematological malignancies
by: Aleksandra Topic, et al.
Published: (2009-01-01)

Recurrence of emphysema post-lung transplantation in a patient with alpha 1 antitrypsin deficiency (AATD)
by: Ali Ataya
Published: (2020-01-01)

Detection of alpha-1 antitrypsin deficiency: the past, present and future
by: Mark Brantly, et al.
Published: (2020-04-01)

The patient profile of individuals with Alpha-1 antitrypsine gene mutations at a referral center in Brazil
by: Manuela Brisot Felisbino, et al.

Prevalence of alpha-1 antitrypsin deficiency and allele frequency in patients with COPD in Brazil
by: Rodrigo Russo, et al.

Clinical Practice Guideline Implementation for Alpha-1 Antitrypsin Deficiency Testing: Evaluation of an Innovative Method
by: Steffen, Priscilla
Published: (2010)

Mineralization of alpha-1-antitrypsin inclusion bodies in Mmalton alpha-1-antitrypsin deficiency
by: Francesco Callea, et al.
Published: (2018-05-01)

Long-term clinical outcomes following treatment with alpha 1-proteinase inhibitor for COPD associated with alpha-1 antitrypsin deficiency: a look at the evidence
by: Franck F. Rahaghi, et al.
Published: (2017-05-01)

Spi2 gene polymorphism is not associated with recurrent airway obstruction and inflammatory airway disease in thoroughbred horses
by: Aline Correa da Silva, et al.
Published: (2011-01-01)

Protease-Specific Biomarkers to Analyse Protease Inhibitors for Emphysema Associated with Alpha 1-Antitrypsin Deficiency. An Overview of Current Approaches
by: Simona Viglio, et al.
Published: (2021-01-01)

Human placental proteomics and exon variant studies link AAT/SERPINA1 with spontaneous preterm birth
by: Bergmann, U., et al.
Published: (2022)

Défice de alfa -1 antitripsina. A experiência do Hospital de Pulido Valente com a terapêutica de reposição Alpha -1 antitrypsin deficiency. The experience of Pulido Valente Hospital with augmentation therapy
by: Carla Alves Costa, et al.
Published: (2009-05-01)

Effect of alpha-1antitrypsin,adiponectine,leptein in obesity
by: Halla G. Mahmood
Published: (2014-01-01)

Identification of bioactive molecules for the treatment of alpha₁-antitrypsin deficiency
by: Ekeowa, Ugochukwu Ifedi
Published: (2012)

Alpha-1 Antitrypsin Deficiency: Home Therapy
by: Anna Annunziata, et al.
Published: (2021-04-01)

Alpha-1 antitrypsin deficiency in the elderly: a case report
by: Anna Annunziata, et al.
Published: (2021-05-01)

The Study of Alterations of alpha – 1 – Antitrypsin (1-AT) in Serum of Hypothyroid Patients
by: Alireza Kheirollah, et al.
Published: (1998-09-01)

Alpha-1 antitrypsin (AAT) augmentation therapy in individuals with the PI*MZ genotype: a pro/con debate on a working hypothesis
by: Igor Barjaktarevic, et al.
Published: (2021-03-01)

Plasma Neutrophil Elastase and its Endogenous Inhibitors as Differential Inflammatory Markers for Dengue and Pneumonia
by: Mamatha Kunder, et al.
Published: (2018-12-01)

Anxiety and depression in patients with alpha-1 antitrypsin deficiency: current insights and impact on quality of life
by: Beiko T, et al.
Published: (2019-07-01)